Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC010473 | Panoply™ Human NNAT Knockdown Stable Cell Line | Inquiry |
| CSC-SC010473 | Panoply™ Human NNAT Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD10869Z | Human NNAT adenoviral particles | Inquiry |
| LV19676L | human NNAT (NM_005386) lentivirus particles | Inquiry |
| LV19677L | human NNAT (NM_181689) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH353344 | shRNA set against Human NNAT (NM_181689.1) | Inquiry |
| SHH353348 | shRNA set against Mouse NNAT (NM_180960.2) | Inquiry |
| SHH353352 | shRNA set against Rat NNAT (NM_053601.2) | Inquiry |
| SHR014528 | shRNA set against Mouse Nnat(NM_010923.2) | Inquiry |
| SHR014546 | shRNA set against Human NNAT(NM_181689.1) | Inquiry |
| SHR014718 | shRNA set against Mouse Nnat(NM_180960.2) | Inquiry |
| SHR014772 | shRNA set against Human NNAT(NM_005386.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFG011940 | Human NNAT cDNA Clone(NM_181689.1) | Inquiry |
| CDFH012628 | Human NNAT cDNA Clone(NM_005386.2) | Inquiry |
| MiUTR1H-06824 | NNAT miRNA 3'UTR clone | Inquiry |
| MiUTR1H-06825 | NNAT miRNA 3'UTR clone | Inquiry |
| MiUTR1M-07718 | NNAT miRNA 3'UTR clone | Inquiry |
| MiUTR1M-07719 | NNAT miRNA 3'UTR clone | Inquiry |
| CDCB156230 | Cynomolgus NNAT ORF clone (XM_005568966.1) | Inquiry |
| CDCB193084 | Rabbit NNAT ORF clone (XM_008256010.1) | Inquiry |
| CDCR249853 | Mouse Nnat ORF Clone(NM_010923.2) | Inquiry |
| CDCR275427 | Mouse Nnat ORF Clone(NM_180960.2) | Inquiry |
| CDCR290377 | Human NNAT ORF Clone(NM_005386.2) | Inquiry |
| CDCR324024 | Human NNAT ORF Clone(NM_181689.1) | Inquiry |
| CDCR380410 | Rat Nnat ORF Clone(NM_053601.2) | Inquiry |
| CDCR382045 | Rat Nnat ORF Clone(NM_181687.2) | Inquiry |
| CDCS412231 | Human NNAT ORF Clone (BC001768) | Inquiry |
Nnat is a brain-specific, highly conserved new gene related to mammalian development. Neuronation (Nnat) is a brain-specific imprinted gene originally cloned from brain in 1996. The human Nnat gene is 3973 bp in length and contains 3 exons and 2 introns. Nnat mRNA has two splicing forms: α and β, both of which have open reading frames in uniform phase, encoding 81 and 54 amino acids, respectively. The difference is that the second exon of β form is cut off.
Figure 1. Schematic representation of the relationship between neuronatin (Nnat) and glucose-induced endoplasmic reticulum (ER) stress in pancreatic b-cells. (Asahara, S. I, et al. 2018)
Nnat Expression
Using Northern blot analysis, it was found that Nnat was selectively expressed in the brain of newborn rats, but not expressed in three tissues such as heart, kidney, and liver. It first appeared in the middle stage of the embryo, at which time the neural tube was closed and neuroepithelial cells began to proliferate. At the peak of neural development at 16 to 19 days, Nnat mRNA expression was significantly enhanced. As the development of the nervous system is completed, its expression declines to the expression level of the adult brain. The transmembrane protein encoded by Nnat may act as a protein ligand, helper, smaller cell adhesion molecule, etc., and participate in the signal of the maturation of the nervous system, development or differentiation of the hindbrain and anterior pituitary.
Subtractive hybridization also confirmed that mouse Nnat expression was down-regulated in P19 embryonic cancer cells, and transiently expressed in rhizomes 3 and 5 of the early hindbrain development and the bottom of the foregut pocket. In the later stage of embryogenesis, the Nnat gene is strongly expressed in the central and peripheral nervous systems. These results indicate that Nnat is involved in the maturation or maintenance of segment identity and nervous system structure during the development of the hindbrain and pituitary. Studies have found that nerve growth factor (NGF) can cause PC12 cell proliferation to stop and transform into a neuronal phenotype, while Nnat mRNA expression is down-regulated. After NGF was removed, Nnat mRNA expression returned to background levels. The role of NGF does not depend on protein and RNA synthesis. Of the two splice forms, only the alpha form is expressed in PC12 cells. In addition, in thyrotropic tumor treated with thyroid hormone, up-regulation of Nnat mRNA expression was also observed.
NNAT and Disease
The expression of two splicing forms of Nnat α and β was detected in three of the four lipoma samples. The gene expression was also detected in tumor cell lines, but not in cultured fibroblasts and adipose tissue. The presence of transcription of Nnat in tumor studies suggests the neural origin of these tumor cells. Similarly, strong expression of Nnat was observed in several patients with pituitary adenomas. However, Nnat mRNA expression was up-regulated in thyroid-stimulating tumors treated with thyroid hormones. Subtractive hybridization analysis demonstrated that Nnat mRNA was present in cell lines expressing thyroid-stimulating hormone, but not in progenitor cell lines expressing alpha subunits. The result may be a calcium-dependent thyroid-stimulating signal transduction pathway.
Studies have shown that the unmethylated Nnat allele is completely missing in the region where the human Nnat gene is located, in leukemia cell lines, and in 20 samples (29 total) of acute myeloid lymphoid leukemia. Through methylation analysis, it was found that Nnat mRNA showed normal methylation in normal hematopoietic progenitor cells and leukemia cells, but gene expression could not be detected in hypermethylated leukemia cells. After demethylation of hypermethylated leukemia cells by treatment with 5'-aza-2'-edoxy cytidine, with the recovery of the normal methylation pattern of the gene, the expression of Nnat was again activated. These results indicate that hypermethylation of the Nnat locus is a common event in children with acute myeloid and lymphoid leukemia. The abnormal methylation of the Nnat locus is the result of 20q11.2 to q12 gene regulation disorders in leukemias.
References: